Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Iraheta, Sandra"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ferra, Christelle *, Terol, María José *, Marquet Palomanes, Juan *, Ramírez Payer, Angel *, Moreno, Carol *, Osorio, Santiago *, De la Cruz, Fátima *, Garcia-Marco, Jose A., Ortiz, Macarena *, Rios Herranz, Eduardo *, Magnano, Laura *, Iraheta, Sandra *, Puerta, Jose Manuel *, de la Serna, Javier *, Smucler, Alicia *, Arguiñano, Jose Maria *, Loscertales, Javier *, Muiña, Begoña *, Fernández, Rubén *, García, Tomas *, Márquez, José A. *, Muntañola Prat, Ana *, Perez Persona, Ernesto *, Yáñez, Lucrecia *, Pérez-Encinas, Manuel *, González Díaz, Marcos *, Caballero, Gonzalo *, Andreu, María Angeles *, Andreu, Rafael *, Ruiz-Zorrilla, Ana *, Moreno, Diana *, Baltasar, Patricia *
Publikováno v:
In Blood 15 November 2022 140 Supplement 1:9908-9910
Autor:
Lakhwani, Sunil, López‐Las Heras, Alberto, Rodríguez‐García, Pablo, Iraheta, Sandra, Martín‐Santos, Taida, Rodríguez‐Salazar, María José, Machado, Patricia, Hernández, Miguel‐Teodoro
Publikováno v:
British Journal of Haematology; Feb2023, Vol. 200 Issue 3, p353-357, 5p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joaquin Martinez-Lopez, Richard Rosenquist, Marcos González, Aliki Xochelli, Stacey Tannheimer, Javier de la Serna, Julian Gorrochategui, Lydia Scarfò, Pamela Ranghetti, Sandra Iraheta, Daniel Primo, Christophe Quéva, Paolo Ghia, Eduardo Anguita, Joan Ballesteros, Veerendra Munugalavadla, Mattias Mattsson, Kostas Stamatopoulos, Ana Belén Espinosa, Alicia Robles, Alberto Chaparro Gil
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Oncotarget
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
instname
Oncotarget
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
PI3Kδ (idelalisib) and BTK (ibrutinib) inhibitors have demonstrated significant clinical activity in chronic lymphocytic leukemia (CLL) interfering with the cross-talk between CLL cells and the lymph node microenviroment, yet their mechanism of acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0bc67af8c22fb588b027a7ac953452
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path[]=25419&path[]=79607
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path[]=25419&path[]=79607
Autor:
Primo D; Vivia Biotech, Tres Cantos, Madrid, Spain., Scarfò L; Strategic Research Program on CLL and B Cell Neoplasia Unit, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy., Xochelli A; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Mattsson M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Ranghetti P; Strategic Research Program on CLL and B Cell Neoplasia Unit, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy., Espinosa AB; Vivia Biotech, Tres Cantos, Madrid, Spain., Robles A; Vivia Biotech, Tres Cantos, Madrid, Spain., Gorrochategui J; Vivia Biotech, Tres Cantos, Madrid, Spain., Martínez-López J; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., de la Serna J; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., González M; Hematology Service, IBSAL-Hospital Universitario, Centro de Investigación del Cáncer (CIC)- IBMCC, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad de Salamanca, Salamanca, Spain., Gil AC; Department of Hematology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.; Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain., Anguita E; Department of Hematology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.; Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain., Iraheta S; Department of Hematology and Hemotherapy, Hospital Universitario de Canarias, La Laguna, Spain., Munugalavadla V; Gilead Sciences, Foster City, CA, USA., Quéva C; Gilead Sciences, Foster City, CA, USA., Tannheimer S; Gilead Sciences, Foster City, CA, USA., Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Ballesteros J; Vivia Biotech, Tres Cantos, Madrid, Spain., Ghia P; Strategic Research Program on CLL and B Cell Neoplasia Unit, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy.
Publikováno v:
Oncotarget [Oncotarget] 2018 May 25; Vol. 9 (40), pp. 26019-26031. Date of Electronic Publication: 2018 May 25 (Print Publication: 2018).